him hers semaglutide Hims & makes deal with Novo in obesity strategy shift Hims & Hers Stock Plunges

In preclinical and clinical investigations, orforglipron is described as the first orally available small molecule with clinically relevant GLP-1 activation, translating an established injection-based mechanism into a tablet (PMC12498447, 2025)

These medications, which mimic the hormones, can enhance insulin release, resulting in a slower digestive process and reduced appetite, thereby encouraging weight loss

The skin settles into its new, improved rhythm

J Neurosci 2009;29:1510015103.ArticlePubMedPMC 57

People with autoimmune conditions or frequent infections should seek medical advice before starting peptide therapy